| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022532 |
| Receipt No. | R000023302 |
| Official scientific title of the study | The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study |
| Date of disclosure of the study information | 2016/05/30 |
| Last modified on | 2018/11/30 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study | |
| Title of the study (Brief title) | The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study | |
| Region |
|
|
| Condition | |||
| Condition | Adult patients scheduled for elective unilateral thoracotomy (lung lobectomy or pulmonary segmentectomy) under combination of general anesthesia and thoracic paravertebral block | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The objective of this study is to determine if an automated intermittent thoracic paravertebral bolus decreases post-thoracotomy pain more effectively when compared with a continuous thoracic paravertebral infusion. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Anesthetized dermatomes by thoracic paravertebral block 24 h after surgery |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Postoperative continuous thoracic paravertebral infusion of 0.2% levobupivacaine at 5 ml/h for 48 h | ||
| Interventions/Control_2 | Postoperative automated intermittent thoracic paravertebral bolus of 0.2% levobupivacaine 10 ml every 2 hours for 48 h | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients undergoing elective unilateral lung lobectomy or pulmonary segmentectomy at Nagasaki University Hospital
2.American Society of Anesthesiologists Physical Status Classification I-III 3.Patients signed the informed consent form |
|||
| Key exclusion criteria | 1.Age < 20 or > 80 years
2.Prior thoracotomy on ipsilateral side 3.Body mass index > 30 kg/m2 4.Body weight < 40 kg 5.Allergy to local anesthetics 6.Contraindication to non-steroidal anti-inflammatory drugs, fentanyl, iodinated contrast medium 7.Hepatic or renal failure 8.Chronic opioid use 9.Pre-existing neurological deficit 10.Infection at the site of injection 11.Bronchial asthma 12.Inability to communicate lucidly |
|||
| Target sample size | 32 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Murata |
| Organization | Nagasaki University Graduate School of Biomedical Sciences |
| Division name | Department of Anesthesiology |
| Address | 1-7-1 Sakamoto, Nagasaki 852-8501, Japan |
| TEL | 095-819-7370 |
| h-murata@nagasaki-u.ac.jp | |
| Public contact | |
| Name of contact person | Hiroaki Murata |
| Organization | Nagasaki University Graduate School of Biomedical Sciences |
| Division name | Department of Anesthesiology |
| Address | 1-7-1 Sakamoto, Nagasaki 852-8501, Japan |
| TEL | 095-819-7370 |
| Homepage URL | |
| h-murata@nagasaki-u.ac.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology, Nagasaki University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Smiths Medical Japan Ltd |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 長崎大学病院(長崎県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023302 |